Predicting the discharge status after liver transplantation at a single center: A new approach for a new era

Liver Transplantation

Volumn 18, Issue 7, 2012, Pages 796-802

  Kelly, Dympna M ^a   Bennett, Renee ^a   Brown, Nancy ^a   McCoy, Judy ^a   Boerner, Derek ^a   Yu, Changhong ^a   Eghtesad, Bijan ^b   Barsoum, Wael ^a   Fung, John J ^a   Kattan, Michael W ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BILIRUBIN; CREATININE;

ADULT; ARTICLE; ASCITES; BODY MASS; CAREGIVER; CASE MANAGER; CHILD TURCOTTE PUGH SCORE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DONOR RISK INDEX; FEMALE; GROUPS BY AGE; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEART EJECTION FRACTION; HEART RIGHT VENTRICLE PRESSURE; HEPATIC ENCEPHALOPATHY; HEPATOPULMONARY SYNDROME; HOME; HOSPITAL CARE; HOSPITAL DISCHARGE; HUMAN; HYDROTHORAX; INTERNATIONAL NORMALIZED RATIO; KARNOFSKY PERFORMANCE STATUS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; NURSE; NURSE MANAGER; NURSING HOME; ORGAN DONOR; PHYSIOTHERAPIST; PREDICTION; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REHABILITATION CENTER; RENAL REPLACEMENT THERAPY; SCORING SYSTEM; SEX DIFFERENCE; SURGEON; SURGICAL MORTALITY;

ADOLESCENT; ADULT; AGED; BODY MASS INDEX; CONTINUITY OF PATIENT CARE; END STAGE LIVER DISEASE; FEMALE; HUMANS; INTERDISCIPLINARY COMMUNICATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MODELS, ORGANIZATIONAL; PATIENT DISCHARGE; TREATMENT OUTCOME;

EID: 84863899726     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23434     Document Type: Article

References (38)

1. Foster RS, Heffler SK,. Updated and extended national health expenditure projections, 2010-2019. Published June 29, 2009. Accessed February 2012.
2. Agency for Healthcare Research and Quality. The Patient Safety and Quality Improvement Act of 2005. Accessed February 2012.
3. HealthCare.gov. Partnership for patients: better care, lower costs. Published December 14, 2011. Accessed February 2012.
4. Young PL, Olsen LA,. The healthcare imperative: lowering costs and improving outcomes: workshop series summary. Published February 24, 2011. Accessed February 2012.
5. Scarborough JE, Pietrobon R, Marroquin CE, Tuttle-Newhall JE, Kuo PC, Collins BH, et al. Temporal trends in early clinical outcomes and health care resource utilization for liver transplantation in the United States. J Gastrointest Surg 2007; 11: 82-88.
6. Åberg F, Isoniemi H, Höckerstedt K,. Long-term results of liver transplantation. Scand J Surg 2011; 100: 14-21.
7. Duffy JP, Kao K, Ko CY, Farmer DG, McDiarmid SV, Hong JC, et al. Long-term patient outcome and quality of life after liver transplantation: analysis of 20-year survivors. Ann Surg 2010; 252: 652-661.
8. Elixhauser A, Steiner CA,. Hospital inpatient statistics, 1996. Accessed February 2012.
9. Fisher ES, Wennberg DE, Stukel TA, Gottlieb DJ, Lucas FL, Pinder EL,. The implications of regional variations in Medicare spending. Part 1: the content, quality, and accessibility of care. Ann Intern Med 2003; 138: 273-287.
10. Fisher ES, Wennberg DE, Stukel TA, Gottlieb DJ, Lucas FL, Pinder EL,. The implications of regional variations in Medicare spending. Part 2: health outcomes and satisfaction with care. Ann Intern Med 2003; 138: 288-298.
11. Fisher ES,. The paradox of plenty: implications for performance measurement and pay for performance. Manag Care 2006; 15 (suppl 8): 3-8.
12. Committee on Quality of Health Care in America. Crossing the quality chasm: a new health system for the 21st century. Accessed February 2012.
13. Hackbarth G, Reischauer R, Mutti A,. Collective accountability for medical care-toward bundled Medicare payments. N Engl J Med 2008; 359: 3-5.
14. Fry DE,. Surgical site infections and the Surgical Care Improvement Project (SCIP): evolution of national quality measures. Surg Infect (Larchmt) 2008; 9: 579-584.
15. Fry DE, Pine M, Jones BL, Meimban RJ,. Surgical warranties to improve quality and efficiency in elective colon surgery. Arch Surg 2010; 145: 647-652.
16. Audimoolam VK, Foxton MR, Agarwal K, O'Grady JG, Heneghan MA,. Predictors of graft and patient survival in subjects undergoing transplantation for hepatitis C virus infection. Liver Transpl 2010; 16: 536-537.
17. Delis SG, Bakoyiannis A, Biliatis I, Athanassiou K, Tassopoulos N, Dervenis C,. Model for End-Stage Liver Disease (MELD) score, as a prognostic factor for post-operative morbidity and mortality in cirrhotic patients, undergoing hepatectomy for hepatocellular carcinoma. HPB (Oxford) 2009; 11: 351-357.
18. Gaynor JJ, Moon JI, Kato T, Nishida S, Selvaggi G, Levi DM, et al. A cause-specific hazard rate analysis of prognostic factors among 877 adults who received primary orthotopic liver transplantation. Transplantation 2007; 84: 155-165.
19. Washburn WK, Meo NA, Halff GA, Roberts JP, Feng S,. Factors influencing liver transplant length of stay at two large-volume transplant centers. Liver Transpl 2009; 15: 1570-1578.
20. Dutkowski P, Oberkofler CE, Béchir M, Müllhaupt B, Geier A, Raptis DA, Clavien PA,. The Model for End-Stage Liver Disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis. Liver Transpl 2011; 17: 674-684.
21. Bruns H, Hillebrand N, Schneider T, Hinz U, Fischer L, Schmidt J, et al. LabMELD-based organ allocation increases total costs of liver transplantation: a single-center experience. Clin Transplant 2011; 25: E558-E565.
22. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783-790.
23. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al.; for United Network for Organ Sharing Liver Disease Severity Score Committee. Model for End-Stage Liver Disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91-96.
24. Touijer K, Scardino PT,. Nomograms for staging, prognosis, and predicting treatment outcomes. Cancer 2009; 115 (suppl): 3107-3111.
25. Potters L, Roach M III, Davis BJ, Stock RG, Ciezki JP, Zelefsky MJ, et al. Postoperative nomogram predicting the 9-year probability of prostate cancer recurrence after permanent prostate brachytherapy using radiation dose as a prognostic variable. Int J Radiat Oncol Biol Phys 2010; 76: 1061-1065.
26. Nixon IJ, Ganly I, Hann LE, Lin O, Yu C, Brandt S, et al. Nomogram for predicting malignancy in thyroid nodules using clinical, biochemical, ultrasonographic, and cytologic features. Surgery 2010; 148: 1120-1127.
27. Oldmeadow LB, McBurney H, Robertson VJ,. Predicting risk of extended inpatient rehabilitation after hip or knee arthroplasty. J Arthroplasty 2003; 18: 775-779.
28. Barsoum WK, Murray TG, Klika AK, Green K, Miniaci SL, Wells BJ, Kattan MW,. Predicting patient discharge disposition after total joint arthroplasty in the United States. J Arthroplasty 2010; 25: 885-892.
29. Wynn, BO, Beckett MK, Hilborne LH, Scott MM, Bahney B,. Evaluation of severity-adjusted DRG systems: interim report. Accessed February 2012.
30. Centers for Medicare and Medicaid Services. Medicare program; proposed changes to the hospital inpatient prospective payment systems and fiscal year 2008 rates. Accessed February 2012.
31. Hughes J,. Development of the 3M™ all patient refined diagnosis related groups (APR DRGs). Accessed February 2012.
32. Salvalaggio PR, Dzebisashvili N, MacLeod KE, Lentine KL, Gheorghian A, Schnitzler MA, et al. The interaction among donor characteristics, severity of liver disease, and the cost of liver transplantation. Liver Transpl 2011; 17: 233-242.
33. Axelrod DA, Schnitzler M, Salvalaggio PR, Swindle J, Abecassis MM,. The economic impact of the utilization of liver allografts with high donor risk index. Am J Transplant 2007; 7: 990-997.
34. Foxton MR, Al-Freah MA, Portal AJ, Sizer E, Bernal W, Auzinger G, et al. Increased Model for End-Stage Liver Disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs. Liver Transpl 2010; 16: 668-677.
35. Carey EJ, Steidley DE, Aqel BA, Byrne TJ, Mekeel KL, Rakela J, et al. Six-minute walk distance predicts mortality in liver transplant candidates. Liver Transpl 2010; 16: 1373-1378.
36. Anderson GF, Frogner BK, Reinhardt UE,. Health spending in OECD countries in 2004: an update. Health Aff (Millwood) 2007; 26: 1481-1489.
37. Kattan MW,. Evaluating a new marker's predictive contribution. Clin Cancer Res 2004; 10: 822-824.
38. Kattan MW, Marasco J,. What is a real nomogram? Semin Oncol 2010; 37: 23-26.